534 related articles for article (PubMed ID: 34425695)
1. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4
Sugden SM; Pham TNQ; Cohen ÉA
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148794
[TBL] [Abstract][Full Text] [Related]
3. Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4
Prévost J; Richard J; Gasser R; Medjahed H; Kirchhoff F; Hahn BH; Kappes JC; Ochsenbauer C; Duerr R; Finzi A
J Virol; 2022 Mar; 96(6):e0192921. PubMed ID: 35080425
[TBL] [Abstract][Full Text] [Related]
4. Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis.
Khan N; Geiger JD
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452331
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
[TBL] [Abstract][Full Text] [Related]
6. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
[TBL] [Abstract][Full Text] [Related]
7. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.
Hopfensperger K; Richard J; Stürzel CM; Bibollet-Ruche F; Apps R; Leoz M; Plantier JC; Hahn BH; Finzi A; Kirchhoff F; Sauter D
mBio; 2020 Jul; 11(4):. PubMed ID: 32665270
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4
Prévost J; Edgar CR; Richard J; Trothen SM; Jacob RA; Mumby MJ; Pickering S; Dubé M; Kaufmann DE; Kirchhoff F; Neil SJD; Finzi A; Dikeakos JD
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941771
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
[TBL] [Abstract][Full Text] [Related]
10. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.
Jafari M; Guatelli J; Lewinski MK
J Virol; 2014 May; 88(9):5062-78. PubMed ID: 24574397
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses.
Prévost J; Pickering S; Mumby MJ; Medjahed H; Gendron-Lepage G; Delgado GG; Dirk BS; Dikeakos JD; Stürzel CM; Sauter D; Kirchhoff F; Bibollet-Ruche F; Hahn BH; Dubé M; Kaufmann DE; Neil SJD; Finzi A; Richard J
mBio; 2019 Jun; 10(3):. PubMed ID: 31213558
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
Wildum S; Schindler M; Münch J; Kirchhoff F
J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
[TBL] [Abstract][Full Text] [Related]
13. Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice.
Sato K; Misawa N; Fukuhara M; Iwami S; An DS; Ito M; Koyanagi Y
J Virol; 2012 May; 86(9):5000-13. PubMed ID: 22357275
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.
Ramirez PW; DePaula-Silva AB; Szaniawski M; Barker E; Bosque A; Planelles V
Retrovirology; 2015 Jul; 12():65. PubMed ID: 26215564
[TBL] [Abstract][Full Text] [Related]
15. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs.
Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374
[TBL] [Abstract][Full Text] [Related]
16. Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.
Umviligihozo G; Cobarrubias KD; Chandrarathna S; Jin SW; Reddy N; Byakwaga H; Muzoora C; Bwana MB; Lee GQ; Hunt PW; Martin JN; Brumme CJ; Bangsberg DR; Karita E; Allen S; Hunter E; Ndung'u T; Brumme ZL; Brockman MA
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376625
[TBL] [Abstract][Full Text] [Related]
17. HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.
Manganaro L; de Castro E; Maestre AM; Olivieri K; García-Sastre A; Fernandez-Sesma A; Simon V
J Virol; 2015 Oct; 89(19):9781-90. PubMed ID: 26178989
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4
Pawlak EN; Dirk BS; Jacob RA; Johnson AL; Dikeakos JD
Retrovirology; 2018 Jan; 15(1):6. PubMed ID: 29329537
[TBL] [Abstract][Full Text] [Related]
19. The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis.
Xu Z; Lodge R; Power C; Cohen EA; Hobman TC
mBio; 2020 Mar; 11(2):. PubMed ID: 32127461
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.
Dubé M; Paquay C; Roy BB; Bego MG; Mercier J; Cohen EA
Traffic; 2011 Dec; 12(12):1714-29. PubMed ID: 21902775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
